About Enal Drugs
Enal Drugs is a company based in Hyderabad (India) founded in 1990. It operates as a B2B. The company has 132 employees as of March 31, 2023. Enal Drugs offers products and services including Active Pharmaceutical Ingredients, Drug Intermediates, Zaleplon Intermediates, Lansoprazole Intermediates, and Omeprazole Intermediates. Enal Drugs operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 132 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Enal Drugs Pvt Ltd.
- Date of Incorporation 27 Jun, 1990
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$8.36 M (USD)7.92as on Mar 31, 2023
-
Net Profit
$22.15 K (USD)-78.85as on Mar 31, 2023
-
EBITDA
$516.99 K (USD)18.16as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
132
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enal Drugs
Enal Drugs offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Drug Intermediates, Zaleplon Intermediates, Lansoprazole Intermediates, and Omeprazole Intermediates.
Raw materials for drug production and formulation
Compounds used in synthesizing pharmaceutical APIs
Specific compounds for Zaleplon API manufacturing
Intermediates for producing Lansoprazole medication
Compounds for Omeprazole and Esomeprazole production
Intermediates used in Rabeprazole API synthesis
Compound for Flecainide anti-arrhythmic drug
Intermediates for antifungal Luliconazole production
Compounds for anticoagulant Edoxaban API
Intermediates for diabetes drug Empagliflozin
Compounds for HIV treatment Dolutegravir API
Intermediates for gout treatment Febuxostat
Funding Insights of Enal Drugs
Detailed funding history for Enal Drugs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enal Drugs
Investment portfolio details for Enal Drugs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enal Drugs
Detailed financials for Enal Drugs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enal Drugs Comparisons
Peer comparison for Enal Drugs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enal Drugs
Enal Drugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Enal Drugs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enal Drugs
Complete news archive for Enal Drugs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enal Drugs
Enal Drugs was founded in 1990.
Enal Drugs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Suresh Babu Sunkaraneni is the current CEO of Enal Drugs.
As of Mar 31, 2023, the latest employee count at Enal Drugs is 132.
Annual revenue of Enal Drugs is $8.36M as on Mar 31, 2023.
Enal Drugs Private Limited is an ISO-certified company that focuses on developing and producing active pharmaceutical ingredients and drug intermediates, including anti-ulcerative drugs. It operates through advanced manufacturing facilities and RD in Hyderabad, India, emphasizing quality control and assurance. The company exports products to Europe, Asia, Africa, and South America, serving international pharmaceutical needs through reliable production processes.
Enal Drugs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Enal Drugs offers Active Pharmaceutical Ingredients, Drug Intermediates, Zaleplon Intermediates, Lansoprazole Intermediates, and 6 more products and services.